Peptable

Comparison

Hexarelin vs LL-37

Function

While Hexarelin is investigated for effects on GH secretion, cardiac protection, and muscle metabolism, with higher GH secretory potency than earlier GHRPs1929, LL-37 acts as a broad-spectrum antimicrobial and immunomodulatory peptide involved in host defense and wound repair, but can also promote inflammation and cancer cell proliferation in some contexts5215.

Mechanism

While Hexarelin works as a potent synthetic hexapeptide (examorelin) that agonizes GHSR-1a to stimulate GH release and also binds CD36, influencing cardiovascular and metabolic pathways19212996, LL-37 is a cationic amphipathic 37-amino-acid cathelicidin peptide generated from hCAP18 that disrupts microbial membranes and modulates innate immunity, including chemotaxis, cytokine induction, and NET formation521586.

Receptor

Hexarelin

Primary: GHSR-1a (ghrelin receptor); also binds the scavenger receptor CD36 in vascular and macrophage tissues192129

LL-37

Functions as a ligand for CXCR2 on neutrophils and other myeloid cells; LL-37 signaling has also been linked to FPR2 and P2X7 in various cell types515

Organism or Origin

Hexarelin

Fully synthetic growth hormone secretagogue29

LL-37

Human cathelicidin antimicrobial peptide generated from the CAP-18 precursor5286

Gene

Hexarelin

GHSR

LL-37

CAMP

Summary

Hexarelin and LL-37 are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Hexarelin is more often discussed in the realm of Metabolic and endocrine and Cardiovascular health, whereas LL-37 is more often associated with the realm of Immunology and inflammation and Gastroenterology. They also influence different molecular systems, with Hexarelin tracking more closely to Ghrelin receptor while LL-37 centers more on GPCR receptor. Hexarelin has a more synthetic design origin, while LL-37 is closer to natural endogenous background and both are still best understood as being in Preclinical development. Hexarelin incorporates d-amino acid substitution and amidation features that are not part of LL-37, while their sequence patterns also diverge, with Hexarelin showing protein-mimetic sequence features and LL-37 showing cationic amphipathic and alpha-helical domain features.

Related articles

No related articles are linked to these peptides yet.

Sources

19Identification of the growth hormone-releasing peptide binding site ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC1133797/
21Hexarelin Peptide | Strength & Recovery - Paragon Sports Medicine, https://www.paragonsportsmedicine.com/peptides/hexarelin
29Examorelin - Wikipedia, https://en.wikipedia.org/wiki/Examorelin
96Growth Hormone Secretagogue Receptor - ScienceDirect.com, https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/growth-hormone-secretagogue-receptor
52Cathelicidin LL-37: A new important molecule in the ... - PMC - NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC7388365/
86Cathelicidin antimicrobial peptide - Wikipedia, https://en.wikipedia.org/wiki/Cathelicidin_antimicrobial_peptide